ON THIS PAGE: You will find information about how many people learn they have AML each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of the screen.
This year, an estimated 18,860 people of all ages (11,530 men and boys and 7,330 women and girls) in the United States will be diagnosed with AML. AML is the second most common type of leukemia diagnosed in both adults and children. An estimated 10,460 deaths (6,010 men and boys and 4,450 women and girls) from AML will occur this year.
The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. The five-year survival rate of people with AML is approximately 24%. However, it is important to note that survival depends on several factors, including biologic features of the disease and, in particular, a patient’s age (see Subtypes  for more information). Although AML is a serious disease, it is treatable and often curable with chemotherapy with or without a stem cell transplant (see the Treatment Options  section).
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with AML. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics .
Statistics adapted from the American Cancer Society's publication, Cancer Facts and Figures 2014.
To continue reading this guide, use the menu on the side of your screen to select another section.